选择性肝动脉栓塞治疗肝血管瘤  

Selective hepatic arterial embolization of hepatic hemangioma

作　　者：李亮[1] 陈广颖 袁家长 魏杰[1] 

机构地区：[1]六安市立医院影像科,六安237000 [2]淮南东方医院集团谢一医院CT室

出　　处：《肝胆外科杂志》2014年第5期358-359,共2页Journal of Hepatobiliary Surgery

摘　　要：目的探讨肝动脉栓塞治疗肝血管瘤选择性的效果。方法对35例肝血管瘤患者使用平阳霉素碘油乳剂行选择性肝动脉栓塞治疗,观察血管瘤大小的变化、临床症状的改善情况。结果对35例肝血管瘤患者成功实施了栓塞治疗。随访3个月～2年,术后病灶不同的程度的缩小,并随时间的增加,呈现进行性的缩小,术后3～6个月、6个月～1年、1年～2年病灶平均缩小率为55.4%、78.2%、81.0%。治疗前的临床症状得到均获得好转或消失。结论选择性肝动脉栓塞是一种安全、有效、创伤小、并发症少的治疗肝血管瘤的方法。Objective To explore the effect of selective hepatic artery embolization of hepatic hemangioma. Methods 35 cases of patients accepted selective hepatic arterial embolization with Pingyangmycin lipiodol emulsion. The change of the hemangioma and the improvement of clinical symptoms was observed. Results 35 cases of hepatic hemangioma patients implemented embolization successfully. Follow- up of 3 months to 2 years,different degrees of reduced increased with time after lesions,which show a progressive narrowing. After 3 to 6 months,6 months to 1 year,1 year to 2years average narrowed lesions was 55. 4%,78. 2%,81%. Clinical symptoms got better or disappear after treatment. Conclusion The selective hepatic artery embolization is a safe,effective,minimally invasive method for the treatment of hepatic hemangioma,which has a few complications.

关 键 词：肝血管瘤 平阳霉素 栓塞 

分 类 号：R735.7[医药卫生—肿瘤]